UnitedHealth Group Incorporated (UNH)
UnitedHealth: When The Tide Goes, Only Financials Will Remain (Technical Analysis)
UNH's sharp decline to $250 is a buying opportunity, supported by strong revenue growth, stable profitability, and resilient dividends. Despite legal and management uncertainties, UNH's financials remain robust, with no operational issues and a forward P/E at historic lows. Dividend growth remains attractive, and my analysis projects strong yield on cost for long-term investors, even in conservative scenarios.
UnitedHealth Built a Giant. Now Its Model Is Faltering.
Growing public scrutiny and tighter regulation are testing a long successful vertical-integration strategy.
S&P 500 Gains & Losses Today: Solar Stocks Fall, UnitedHealth Shares Jump
Major U.S. equities indexes ticked higher to kick off the trading week, bolstered by outperformance in biotech and the health care sectors even as investors digested the downgraded view on U.S. government creditworthiness from ratings agency Moody's.
UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
By mid-May 2025, the company's stock price had dropped over 40% year-to-date, raising concerns about its immediate future. However, substantial price declines in leading companies can create attractive investment opportunities.
How Bill Ackman predicted UnitedHealth stock crash two months early
While the deluge of recent negative news has made it apparent to all that UnitedHealth (NYSE: UNH) stock is in dire straits, Bill Ackman saw the writing on the wall months in advance.
Cramer's Mad Dash: UnitedHealth
Jim Cramer breaks down why he's keeping an eye on shares of UNH.
Analysts update UnitedHealth stock price after historic free-fall
Wall Street analysts have issued a bearish outlook for UnitedHealth (NYSE: UNH) stock following a tumultuous week that saw the healthcare giant's shares plummet 23%.
Follow UNH Insiders as They Buy $30 Million Worth of Stock?
Though UnitedHealth Group faces a barrage of negative news, recent heavy insider buying and technical indicators suggest peak pessimism and a potential bottom in the stock.
UNH: Best Time Ever To Buy For Income Investors
UnitedHealth's shares have plunged, but the sell-off creates a rare opportunity: the dividend yield is at a historic high and the valuation is compelling. Despite near-term headwinds—guidance withdrawal, CEO change, and reported DOJ probe—I see long-term prospects as strong, with robust earnings and dividend growth expected. UNH's payout ratio is low, and dividend growth history is excellent; even conservative growth assumptions point to attractive total returns for income investors.
Why UnitedHealth Is Down 50% In A Month And What Happens Next
Trump wants to cut out the middleman, will he be able to? UNH's exposure to PBM risks is real, but is the market pricing in the worst-case scenario. I look at the legal and regulatory routes to reform, as well as financial estimates on UNH of my base case.
UnitedHealth: An Investment Worth Considering At The Right Price
UnitedHealth faces significant headwinds, but the issues are fixable. The CEO replacement is highly positive, since Stephen J. Hemsley has a proven track record and over $350M worth of shares. The aging population and higher interest rates support long-term growth.
UnitedHealth stock hit with monster insider trade after massive free-fall
UnitedHealth Group (NYSE: UNH) has seen a notable wave of insider buying, reflecting a concerted effort by its board to restore investor confidence following a turbulent period.
